[美法仑和肿瘤坏死因子对恶性黑色素瘤肢体进行孤立性热灌注]
[Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor].
作者信息
Kettelhack C, Hohenberger P, Schlag P M
机构信息
Humboldt-Universität, Virchow-Klinikum, Robert-Rössle-Klinik, Berlin.
出版信息
Langenbecks Arch Chir Suppl Kongressbd. 1996;113:127-9.
PMID:9101810
Abstract
Isolated limb perfusion (ILP) with tumor necrosis factor (TNF) and melphalan was carried out in 21 patients with regionally metastatic malignant melanoma of the limbs. The observed response rate was 65% complete and 15% partial remission. These results warrant further investigation of ILP with TNF and melphalan vs ILP with melphalan alone in a prospective randomised multicenter trial.
摘要
对21例肢体局部转移性恶性黑色素瘤患者进行了肿瘤坏死因子（TNF）和美法仑的离体肢体灌注（ILP）治疗。观察到的缓解率为完全缓解65%，部分缓解15%。这些结果值得在前瞻性随机多中心试验中进一步研究TNF和美法仑联合ILP与单纯美法仑ILP的疗效对比。
相似文献
1
[Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor].[美法仑和肿瘤坏死因子对恶性黑色素瘤肢体进行孤立性热灌注]
Langenbecks Arch Chir Suppl Kongressbd. 1996;113:127-9.
2
Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.在先前灌注失败后，对复发性肢体黑色素瘤重复使用肿瘤坏死因子α和马法兰进行孤立肢体灌注。
Eur J Surg Oncol. 2006 Apr;32(3):318-24. doi: 10.1016/j.ejso.2005.10.009. Epub 2006 Jan 18.
3
Isolated limb perfusion for unresectable melanoma of the extremities.肢体孤立灌注治疗四肢不可切除的黑色素瘤。
Arch Surg. 2004 Nov;139(11):1237-42. doi: 10.1001/archsurg.139.11.1237.
4
Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone.美法仑与肿瘤坏死因子-α 进行离体肢体灌注后的局部毒性与单独使用美法仑后的毒性比较。
Eur J Surg Oncol. 2001 Jun;27(4):390-5. doi: 10.1053/ejso.2001.1124.
5
Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.用美法仑重复进行肢体隔离灌注治疗肢体复发性黑色素瘤。
J Am Coll Surg. 1996 Jun;182(6):467-72.
6
Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.美法仑单独热灌注隔离肢体与美法仑加肿瘤坏死因子的随机多中心试验：美国外科医师学会肿瘤学组Z0020试验
J Clin Oncol. 2006 Sep 1;24(25):4196-201. doi: 10.1200/JCO.2005.05.5152.
7
Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure.肿瘤坏死因子α和美法仑重复进行孤立肢体灌注治疗先前孤立肢体灌注失败患者多发皮下转移灶的疗效。
Ann Surg Oncol. 2005 Aug;12(8):609-15. doi: 10.1245/ASO.2005.03.060. Epub 2005 Jun 22.
8
[Isolated hyperthermic limb perfusion with melphalan and tumor necrosis factor in malignant melanoma].[美法仑和肿瘤坏死因子在恶性黑色素瘤中的肢体隔离热灌注治疗]
Dtsch Med Wochenschr. 1997 Feb 14;122(7):177-81. doi: 10.1055/s-2008-1047593.
9
Hyperthermic isolation limb perfusion with TNFalpha in the treatment of in-transit melanoma metastasis.肿瘤坏死因子α热灌注隔离肢体治疗肢体移行性黑素瘤转移
In Vivo. 2006 Nov-Dec;20(6A):739-42.
10
Hyperthermic isolated limb perfusion with tumor necrosis factor is a useful therapy for advanced melanoma of the limbs.肿瘤坏死因子介导的高温离体肢体灌注是治疗晚期肢体黑色素瘤的有效方法。
J Clin Oncol. 2007 Apr 10;25(11):1449-50; author reply 1450-1. doi: 10.1200/JCO.2006.09.8459.
Zotero 插件